548 related articles for article (PubMed ID: 11738071)
1. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery.
Chen TT; Jiandong-Liu ; Wang G; Jiang SL; Li LB; Gao CQ
Heart Surg Forum; 2013 Feb; 16(1):E38-47. PubMed ID: 23439357
[TBL] [Abstract][Full Text] [Related]
3. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
Ray MJ; Marsh NA; Hawson GA
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
[TBL] [Abstract][Full Text] [Related]
4. Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass.
Ray MJ; Hales M; Marsh N
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):129-35. PubMed ID: 11302475
[TBL] [Abstract][Full Text] [Related]
5. Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass.
Couturier R; Rubatti M; Credico C; Louvain-Quintard V; Anerkian V; Doubine S; Vasse M; Grassin-Delyle S
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):259-65. PubMed ID: 24418941
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M
BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
8. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
9. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.
Páramo JA; Rifón J; Llorens R; Casares J; Paloma MJ; Rocha E
Haemostasis; 1991; 21(1):58-64. PubMed ID: 1907591
[TBL] [Abstract][Full Text] [Related]
10. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
de Haan J; van Oeveren W
Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
[TBL] [Abstract][Full Text] [Related]
11. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
Mastroroberto P; Chello M; Zofrea S; Marchese AR
Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
[TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
[TBL] [Abstract][Full Text] [Related]
13. The influence of retinal detachment surgery on perioperative blood fibrinolysis.
Malukiewicz-Wiśniewska G; Kotschy M; Kałuzny J
Curr Eye Res; 1999 Aug; 19(2):123-30. PubMed ID: 10420181
[TBL] [Abstract][Full Text] [Related]
14. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
15. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
Guler N; Burleson A; Syed D; Banos A; Hopkinson W; Hoppensteadt D; Rees H; Fareed J
Clin Appl Thromb Hemost; 2016 May; 22(4):372-6. PubMed ID: 26207021
[TBL] [Abstract][Full Text] [Related]
18. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.
Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA
J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308
[TBL] [Abstract][Full Text] [Related]
20. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.
Ray MJ; Marsh NA
Thromb Haemost; 1997 Sep; 78(3):1021-6. PubMed ID: 9308747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
